China 
Africa 
Explore chapters and articles related to this topic
Biopsy etc. Procedures and Bronchography.
Published in Fred W Wright, Radiology of the Chest and Related Conditions, 2022
Dionosil (propyliodone - the propyl ester of diodone) became available in 1952, either as a suspension in arachis oil or water. Its advantage was that if it passed peripherally into the bronchioles and alveoli, from which it cannot be expectorated, it was hydrolysed, absorbed and excreted. With the very small number of bronchograms carried out, as a result of CT and fibreoptic bronchoscopy, it was withdrawn from the market by Glaxo in 1990. The author never had a case of allergy to the arachis oil, although a few patients with asthma had some bronchospasm (usually relieved by IV aminophylline) - none were severe - but one carried out elsewhere showed severe spasm (Illus. BRONCHOGRAM, Pt. 7b & c).
Common Cosmetic Ingredients: Chemistry, Actions, Safety and Products
Published in Heather A.E. Benson, Michael S. Roberts, Vânia Rodrigues Leite-Silva, Kenneth A. Walters, Cosmetic Formulation, 2019
Peanut oil (arachis oil) is the refined fixed oil extracted from the kernels of Arachis hypogaea. Peanut oil is used in skin care products and cosmetics to soften and protect the skin. When ingested orally peanut proteins are a major cause of serious allergy in humans, including hives. Refined peanut oil is very low in the proteins that cause allergy. Case reports of allergy to topical peanut oil are rare. There is no reliable data to indicate that skin care products and cosmetics containing peanut oil cause allergy in sensitive individuals when used topically (Ring and Möhrenschlager, 2007).
Aural formulations
Published in Karen Anne Gunnell, Rebecca Hayley Venables, A Practical Guide to Medicines Administration, 2018
Karen Anne Gunnell, Rebecca Hayley Venables
Some aural formulations contain arachis oil (peanut oil). The British National Formulary states that, as the oil is refined, it is unlikely to cause a reaction in patients with a known peanut allergy.2 However, the Committee on Safety of Medicines (CSM) recommends that patients with a peanut allergy should not use medicines containing arachis oil.3 In addition, some SPCs recommend that patients allergic to soya also avoid these products.
Ameliorating the in vivo antimalarial efficacy of artemether using nanostructured lipid carriers
Published in Journal of Microencapsulation, 2018
Ravisankar Vanka, Gowthamarajan Kuppusamy, Simhadri Praveen Kumar, Uday Krishna Baruah, Veera Venkata Satyanarayana Reddy Karri, Vimal Pandey, Phanithi Prakash Babu
We chose intraperitoneal route for administering drugs. Briefly, animals were administered with ARM (5 mg/kg body weight) dissolved in the arachis oil, NLC-7 (5 mg/kg body weight). Experimental groups were made as follows: Animals (I) Control (healthy animals); (II) Infected animals (CM); (III) Pure drug (ARM) treated; (IV) Blank formulation (B-NLC) treated; and (V) Formulation (NLC-7) treated. Treatment was started after onset of the symptoms of CM i.e. on day 6th–9th post infection and administration was continued till one week through intraperitoneally.